An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
Clinical trial NCT03533283 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03533283
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-08
- Primary completion
- 2026-10-16
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.